▶ Plasmapp exported its premium and universal sterilizers to the top two distributors in the North American veterinary market.

▶ Plasmapp's new model, the Universal product, received an initial order from Covetrus, the largest distributor in the United States, filling a 40-ton container and shipping approximately $1 million worth of sterilizer products to the U.S. on the 29th.

▶ Plasmapp's universal sterilizer product is currently undergoing medical device certification in Japan, with sales expected to focus on the Japanese dental market in the latter half of the year. Plasmapp is also preparing for release with domestic implant manufacturers.

▶ With the launch of Plasmapp's new products, it is anticipated to become a "export winner" in the North American veterinary market and the global dental market.

Plasma technology venture company Plasmapp (405000) exported its premium and universal plasma sterilizers to the top two distributors in the North American veterinary market, loading two containers for export and shipping approximately $1 million worth of sterilizer products to the United States on the 29th.

Plasmapp entered the U.S. veterinary market through the second-largest distributor in North America in 2020, selling its existing premium sterilizer product (STERLINK plus) and steadily growing its brand in the market. Recently, by launching the sterilizer universal lineup (STERLINK U510), Plasmapp began selling to the largest distributor in North America, Covetrus, creating a competitive landscape where the top two companies in the North American veterinary market compete to sell Plasmapp sterilizer products.

The new product line from Plasmapp, the Universal lineup, saw significant sales improvement in the domestic dental market when the primary model (STERLINK U420) was launched in the second half of last year. The secondary model (STERLINK U510), launched in the North American veterinary market earlier this year, is expected to position Plasmapp products dominantly in the U.S. veterinary market by leveraging the competitive structure of the top two distributors. Plasmapp's Universal lineup is a product developed to meet high demand for product economy in the veterinary and dental markets, starting from the domestic dental market and successfully expanding to the North American veterinary market. Plasmapp plans to further expand its market application to the global dental market.

Plasmapp's CEO, Youbong Lim, explained, "The sterilizer segment in the global medical device market is steadily growing at a rate of around 10%, and our Plasmapp sterilizer (STERLINK) is driving steady sales growth in the market," emphasizing the importance of global partnerships through sterilizer products, such as plasma surface treatment devices (ACTILINK) and therapy devices (STIMLINK), for immediate market entry into dental, plastic surgery, orthopedic surgery, and dermatology markets. This year, Plasmapp has demonstrated its determination to turn a profit.

Plasmapp emerges as 'Export winner' with Sterilizers, Shipping to the North American Veterinary Market and Forging Partnerships.